4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-008733
10% owner sold 220,714 shares at an average $33.68 ($7,433,459)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morningside Venture Investments Ltd 10% owner | 2023-03-14 | Sale | −70,714 | $34.54 | $2,442,462 | 7,409,884 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-03-15 | Sale | −108,934 | $33.12 | $3,607,894 | 7,300,950 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-03-15 | Sale | −41,066 | $33.68 | $1,383,103 | 7,259,884 | D |
| Open-market sales · 220,714 sh · avg $33.68 · $7,433,459 | |||||||
Loading xslF345X03/doc4.xml…